open access

Vol 56, No 1 (2005)
Original papers
Published online: 2006-03-22
Submitted: 2013-02-15
Get Citation

Serum alpha-subunit elevation after TRH administration: a valuable test in presurgical diagnosis of gonadotropinoma?

Anna Gruszka, Jolanta Kunert-Radek, Marek Pawlikowski
Endokrynologia Polska 2005;56(1):14-18.

open access

Vol 56, No 1 (2005)
Original papers
Published online: 2006-03-22
Submitted: 2013-02-15

Abstract

Objectives: Clinically nonfunctioning pituitary adenomas (CNFPAs) represent about 30% of pituitary macroadenomas, gonadotropinomas being the most frequent among them. The aim of the present study is to re-evaluate the usefulness of the measurement of α-SU serum level in response to TRH stimulation in detecting the gonadotropic nature of nonfunctioning pituitary adenomas before the neurosurgical treatment.
Material and methods: We have studied 14 patients with CNFPAs. The response of α-SU to the administration of TRH was studied in each patient before the surgery. α-SU blood serum level increase over 50% of the baseline level after TRH treatment was considered to be significant.
Results: The patients were divided into 2 groups, each including 7 subjects. The first group included the patients with gonadotropinomas (tumors immunopositive for FSH and/or LH or their free subunits). The second group included the patients with adenomas immunonegative for gonadotropins and α-SU. The basal level of α-SU was elevated over the upper limit of normal range in two patients of the first group (gonadotroph adenomas) and in one in the second group. All but one patient from the first group and none of seven patients with tumors immunonegative for FSH, LH or α-SU, had a significant α-SU (over 50%) response to TRH. In three of seven patients with gonadotropins immunonegative tumors a decrease of α-SU serum level after TRH was observed.
Conclusion: The measurement of α-SU serum level in response to TRH administration seems to be useful in preoperative identification of gonadotroph adenomas among other nonfunctioning pituitary adenomas.

Abstract

Objectives: Clinically nonfunctioning pituitary adenomas (CNFPAs) represent about 30% of pituitary macroadenomas, gonadotropinomas being the most frequent among them. The aim of the present study is to re-evaluate the usefulness of the measurement of α-SU serum level in response to TRH stimulation in detecting the gonadotropic nature of nonfunctioning pituitary adenomas before the neurosurgical treatment.
Material and methods: We have studied 14 patients with CNFPAs. The response of α-SU to the administration of TRH was studied in each patient before the surgery. α-SU blood serum level increase over 50% of the baseline level after TRH treatment was considered to be significant.
Results: The patients were divided into 2 groups, each including 7 subjects. The first group included the patients with gonadotropinomas (tumors immunopositive for FSH and/or LH or their free subunits). The second group included the patients with adenomas immunonegative for gonadotropins and α-SU. The basal level of α-SU was elevated over the upper limit of normal range in two patients of the first group (gonadotroph adenomas) and in one in the second group. All but one patient from the first group and none of seven patients with tumors immunonegative for FSH, LH or α-SU, had a significant α-SU (over 50%) response to TRH. In three of seven patients with gonadotropins immunonegative tumors a decrease of α-SU serum level after TRH was observed.
Conclusion: The measurement of α-SU serum level in response to TRH administration seems to be useful in preoperative identification of gonadotroph adenomas among other nonfunctioning pituitary adenomas.
Get Citation

Keywords

α-subunit; TRH test; pituitary tumors; gonadotropinoma

About this article
Title

Serum alpha-subunit elevation after TRH administration: a valuable test in presurgical diagnosis of gonadotropinoma?

Journal

Endokrynologia Polska

Issue

Vol 56, No 1 (2005)

Pages

14-18

Published online

2006-03-22

Bibliographic record

Endokrynologia Polska 2005;56(1):14-18.

Keywords

α-subunit
TRH test
pituitary tumors
gonadotropinoma

Authors

Anna Gruszka
Jolanta Kunert-Radek
Marek Pawlikowski

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl